Ibaraki, Japan

Jun-ichi Shishikura

This inventor holds 3 USPTO granted patents. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun-ichi Shishikura. Retrieved from https://idiyas.com/inventor/jun-ichi-shishikura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.4

ph-index = 3

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jun-ichi Shishikura: Innovator in Neurotoxicity Inhibition

Jun-ichi Shishikura is a notable inventor based in Ibaraki, Japan. With a total of three patents to his name, he has made significant contributions to the field of pharmaceuticals, particularly in neurotoxicity.

Latest Patents

Shishikura's latest patents include an inhibitor of kainic acid neurotoxicity, which aims to mitigate harmful effects on the nervous system. Another important patent is related to pyridothiazine derivatives that have shown potential in various medicinal applications. Lastly, he has developed imidazole-substituted quinoxalinedione derivatives, which may serve valuable purposes in drug development.

Career Highlights

Currently, Jun-ichi Shishikura works at Yamanouchi Pharmaceutical Company Ltd., where he has been pivotal in research and development initiatives. His work focuses on innovative solutions that address significant health challenges, contributing to the advancement of pharmaceutical sciences.

Collaborations

Throughout his career, Shishikura has collaborated with esteemed colleagues such as Shuichi Sakamoto and Masamichi Okada. These collaborations have fostered an environment of creativity and shared knowledge, leading to breakthroughs in their respective research areas.

Conclusion

In summary, Jun-ichi Shishikura stands out as an influential inventor in the field of pharmaceuticals, particularly with his innovative approaches to neurotoxicity. His dedicated work at Yamanouchi Pharmaceutical Company Ltd. and fruitful collaborations enhance his impact on the industry, paving the way for future advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…